<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Hematopathology on Leukoformula</title><link>https://www.leukoformula.com/en/tags/gematopatologiya/</link><description>Recent content in Hematopathology on Leukoformula</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Fri, 09 Oct 2026 15:00:00 +0300</lastBuildDate><atom:link href="https://www.leukoformula.com/en/tags/gematopatologiya/feed.xml" rel="self" type="application/rss+xml"/><item><title>Primary Myelofibrosis MF-3 in Bone Marrow Biopsy</title><link>https://www.leukoformula.com/en/post/pervichnyy-mielofibroz-mf-3-v-biopsii-kostnogo-43073/</link><pubDate>Fri, 09 Oct 2026 15:00:00 +0300</pubDate><guid>https://www.leukoformula.com/en/post/pervichnyy-mielofibroz-mf-3-v-biopsii-kostnogo-43073/</guid><description>&lt;p>Myelofibrosis in advanced stage (MF-3)&lt;/p>
&lt;p>Dense reticulin fibers and intrasinusoidal hematopoiesis in a case of advanced PMF (MF-3)&lt;/p>
&lt;p>Sample type: Bone marrow biopsy
Staining type: Reticulin by Wilder&amp;rsquo;s method
Author(s): H.M. Raya, J. Alvarez-Argüelles, L. Hernández
Workplace: University Hospital of the Canary Islands, University of La Laguna&lt;/p></description></item><item><title>Reflexive Testing in Laboratory Hematopathology</title><link>https://www.leukoformula.com/en/post/refleksivnoe-testirovanie-v-laboratornoy-42947/</link><pubDate>Sat, 03 Oct 2026 20:00:00 +0300</pubDate><guid>https://www.leukoformula.com/en/post/refleksivnoe-testirovanie-v-laboratornoy-42947/</guid><description>&lt;p>🩺 Reflexive Testing in Hematopathology: Balancing Efficiency and Ethics&lt;/p>
&lt;p>In modern laboratory diagnostics, there is a practice called “reflexive testing.” This is a situation where a hematopathologist, after analyzing primary results, uses their discretion to order additional tests on already existing biomaterial. This allows for faster diagnosis without repeated blood draws.&lt;/p></description></item><item><title>Hematopathology in Morphological Diagnostics System</title><link>https://www.leukoformula.com/en/post/gematopatologiya-v-sisteme-morfologicheskoy-20193/</link><pubDate>Fri, 13 Sep 2024 09:00:00 +0300</pubDate><guid>https://www.leukoformula.com/en/post/gematopatologiya-v-sisteme-morfologicheskoy-20193/</guid><description>&lt;p>🩸 Hematopathology - the queen of beauty in morphology, agree?&lt;/p></description></item><item><title>Follicular Dendritic Cell Sarcoma: Cytology of a Rare Tumor</title><link>https://www.leukoformula.com/en/post/sarkoma-iz-follikulyarnyh-dendriticheskih-kletok-19913/</link><pubDate>Fri, 06 Sep 2024 10:09:21 +0300</pubDate><guid>https://www.leukoformula.com/en/post/sarkoma-iz-follikulyarnyh-dendriticheskih-kletok-19913/</guid><description>&lt;p>Clinical case of follicular dendritic cell sarcoma.
A 63-year-old woman. Excisional biopsy of a cervical lymph node was performed. Based on the results of histological and immunohistochemical studies, follicular dendritic cell sarcoma (FDCS) was diagnosed. Expression of CD21 and CD23 was detected in tumor cells. Ki67 expression level was 30-40%. Expression of pancytokeratin, CK5/6, CD30, CD45, CD68, Sox-10, LMP-1, podoplanin, CD68 was absent in atypical cells.
FDCS is a malignant tumor exhibiting morphological and phenotypic characteristics of follicular dendritic cells, which are cells of stromal origin and normally found in germinal centers. FDCS is an extremely rare tumor, difficult for both histological and, even more so, cytological diagnosis. According to the WHO classification, FDCS can mimic a wide range of tumors, such as unclassified pleomorphic sarcoma, meningioma, thymoma, thymic carcinoma, angiosarcoma, undifferentiated carcinoma, lymphoepithelial carcinoma, and gastrointestinal stromal tumor. The diagnostic problem can only be solved by applying a panel of immunohistochemical markers.
In the presented material, you can see touch imprints of the lymph node. Cytological diagnosis can be extremely difficult. Typically, these are hypercellular smears in which large tumor cells are visible against a background of small lymphocytes, plasma cells, and histiocytes, arranged both as syncytial sheets and individually. The cytological characteristics of tumor FDCS described in the literature can be variable. Nuclei are round, ovoid, polygonal, and spindle-shaped, and can be tightly apposed or overlap. Nuclear chromatin is vesicular or finely granular, nucleoli are of different sizes. Grooves and pseudoinclusions may be present in the nuclei. Bi- and multinucleated cells are found, sometimes resembling Reed-Sternberg cells. The cytoplasm is medium-sized or wide, pale eosinophilic. In FNA cytological smears, long cytoplasmic processes that form an intersecting network can sometimes be seen. This is not visible in our preparation, as it is not an aspirate smear, but a tissue imprint. Mitoses, pronounced nuclear atypia, and necrosis may be present.
👉 The clinical case was kindly provided by the laboratory physician, pathologist, member of the FLM hematology committee &lt;a href="https://vk.com/id995810" target="_blank" rel="noopener nofollow ugc">Elena Belyakova&lt;span class="link-ext" aria-hidden="true">↗&lt;/span>&lt;/a>, Department of Molecular Morphology, E.E. Eichwald Clinic, I.I. Mechnikov Northwestern State Medical University, St. Petersburg.&lt;/p></description></item><item><title>Cytoplasmic Inclusions in Neoplastic Lymphocytes</title><link>https://www.leukoformula.com/en/post/citoplazmaticheskie-vklyucheniya-v-opuholevyh-17758/</link><pubDate>Tue, 28 May 2024 11:06:40 +0300</pubDate><guid>https://www.leukoformula.com/en/post/citoplazmaticheskie-vklyucheniya-v-opuholevyh-17758/</guid><description>&lt;p>🔬Filamentous, spaghetti-like inclusions in the cytoplasm in lymphoproliferative disease.&lt;/p>
&lt;p>👉Source: Löffler H. - Atlas of clinical hematology, 6-ed Revised, 2012&lt;/p></description></item></channel></rss>